{
  "id": 9826647,
  "title": "FDA Approves Efsitora Weekly Insulin for Type 2 Diabetes",
  "url": "https://urgent.news/2026/09/25/fda-approves-efsitora-weekly-insulin-for-type-2-diabetes",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-25T19:22:27.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/endocrinology/diabetes/123153"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- The FDA approved the once-weekly basal insulin efsitora (Onswik), drugmaker Eli Lilly announced on Thursday. Indicated as an adjunct to diet and exercise for adults with type 2 diabetes, the therapy delivers steady basal insulin...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}